🔗 Share this article

An underground economy for unapproved weight-loss drugs is being driven by social media fitness personalities and sellers on messaging platforms, according to new investigations.

Experimental Drug Acquiring Traction Via Social Media

The experimental drug, which is still in research studies, is being promoted by social media influencers for its supposed fat-burning effects. Followers are encouraged to message these profiles directly for source information, while also obtaining discount codes.

Active Commerce on Messaging Platforms

Separately, a flourishing trade exists on Telegram, where groups with thousands of members share comparison photos, injection guides and claims of rapid UK delivery. Sellers promote the drug there before redirecting customers to WhatsApp for purchases.

Learning About The Experimental Drug

This medication is an investigational injection developed by US drugmaker Eli Lilly. The drug targets three intestinal hormones – GLP-1, GIP and pancreatic hormone. Preliminary studies indicate it could assist patients lose up to a quarter of their total weight. Referred to as the “triple G”, the drug is being hailed online as the next Ozempic.

Healthcare Professionals Express Worries

Nevertheless, doctors and pharmacists have cautions that the sale of what is still an unapproved drug in the UK is a cause for concern and could lead to individuals injecting substances of unknown origin.

Several professionals said the demand for retatrutide could be connected to the increasing price of approved slimming products such as Mounjaro.

Legal Status and Enforcement

Marketing retatrutide on TikTok or Telegram is prohibited in the UK, as it is an unapproved drug that must not be marketed or supplied for personal consumption under the Human Medicines Regulations 2012.

Some influencers try to circumvent the rules by calling to the drug as a “research chemical” or describing it as “not for human consumption”. Retatrutide is not a controlled drug, but promotion and distribution can still breach pharmaceutical, marketing, and consumer laws, potentially leading to fines, legal action or prison.

Service Reaction and Content Elimination

According to the social media company, the service has removed problematic material and banned related hashtags and search suggestions. The organization stated it was dedicated to keeping the platform safe and investing in enhancing compliance measures.

Online Trading Activities

Research also found communities with up to 9,000 participants marketing the experimental drug using Telegram's built-in search feature, which functions like a public directory. Entering “retatrutide” immediately displays channels with thousands of users, populated with images of slimming results, positive reviews and detailed instructions for mixing or administering at residence.

Within minutes of entering one community, a vendor posted contact information, where the majority of transactions occur. The seller sent an instruction manual and promised shipping within two days. When questioned whether the substance was authentic, one vendor said: “You can’t be sure.” Another provided a image of a alleged testing documentation. Not one inquired about weight, medical conditions or past usage.

Product Information and Costs

Inside these communities, messages show black plastic packages with Royal Mail stickers, claiming to contain new batches. One communication read: “It took eight of us to load them this morning.”

Buyers can choose between dry substance containers, mixed at residence with sterile water, or ready-to-use pens typically priced at 160 pounds for 20mg. When questioned how long a injector should last, vendors give conflicting responses varying between a few weeks to “depends on your body”.

Service Oversight and Safety Measures

A spokesperson for the messaging service said it actively moderated harmful content on its service including content that promoted the “misuse of controlled medications”. The organization noted that it removed “millions of pieces of harmful content each day”.

Medical Expert Warnings

“Individuals are injecting materials they cannot confirm. Even if the science behind this drug is sound, these digital versions may not include what they advertise,” said a pharmacy expert, the head of pharmaceutical services at a pharmacy service.

A medical professional of Asda Online Doctor connected the surge in demand to recent price rises for approved weight-loss drugs such as Mounjaro. “With costs increasing, individuals are using social media. But fake treatments are extremely risky. You cannot know what’s inside or whether the environment they were made in was clean,” she explained.

Her staff has previously encountered patients harmed by personal administration from unconfirmed suppliers. “We understand the disappointment, but purchasing from Telegram or communication platforms is gambling with your health,” stated the doctor. “These substances could be contaminated or incorrectly dosed.”

Producer Position

A representative from Eli Lilly said retatrutide was in phase 3 research studies and had not been evaluated or approved by any regulatory agency anywhere in the world. “Therefore at this point no one can market [it] for human use,” they explained, noting that any product “falsely representing itself as a company experimental substance not yet authorized … may expose users to potentially significant health risks”.